大和:維持吉利(0175.HK)“買入”評級 目標價20港元
大和發佈報告稱,吉利汽車(0175.HK)去年12月銷售量同比增長39%,去年全年總銷量約136.16萬部,符合吉利此前136萬部的目標。吉利今年的銷售目標為141萬部,即同比升3.6%,有關目標相對保守。該行原先則估計會同比增長9%,相信吉利在豐富的產品渠道及市場膚色下支持下,今年可望超越銷售目標。
該行表示,維持吉利“買入”評級,目標價20港元。
該行預計,今年下半年行業數據可逐步改善,今年盈利強勁復甦,主要受到銷售及利潤上升所帶動。另外,去年12月Lynk&Co品牌銷售量同比增長87%,增速高於11月的15%,主要因去年同期的低基數,而去年全年有關品牌同比增幅達6%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.